◼ Archived
Business
Lilly snags another Massachusetts biotech as local headcount surges past 1,400
Eli Lilly's $2.88 billion bid for Merida Biosciences marks its 13th 2026 acquisition, swelling Massachusetts biotech staffing.
Biotech M&A
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Biotech M&A
This hub groups 2 separate news trends connected to Biotech M&A, spanning July 7, 2026 through September 1, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 19 article observations and 15 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 holds ✓
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is expanding into endocrinology with a record-breaking $10 billion acquisition of biotech specialist Crinetics.